Arthur Fratamico's Net Worth
$198 Thousand
Who is Arthur Fratamico?
Arthur Fratamico does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Panbela Therapeutics, Inc., Galera Therapeutics, Inc., Vitae Pharmaceuticals, Inc, and Flexion Therapeutics Inc.
SEC CIK
Arthur Fratamico's CIK is 0001598129
Past Insider Trading and Trends
2020 was Arthur Fratamico's most active year for acquiring shares with 5 total transactions. Arthur Fratamico's most active month to acquire stocks was the month of November. 2016 was Arthur Fratamico's most active year for disposing of shares, totalling 6 transactions. Arthur Fratamico's most active month to dispose stocks was the month of September. 2015 saw Arthur Fratamico paying a total of $78,266.00 for 23,750 shares, this is the most they've acquired in one year. In 2016 Arthur Fratamico cashed out on 226,656 shares for a total of $3,350,455.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Panbela Therapeutics, Inc. (PBLA) Snapshot price: $1.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
| +81.45% | 4.32K |
—
|
—
| 9.62K |
May 25
| |||
Form 4
| +118.61% | 2.88K |
—
|
—
| 5.3K |
Dec 1
| |||
Form 4
|
∞
| 2.42K |
—
|
—
| 2.42K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1708
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vitae Pharmaceuticals, Inc No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.23K |
$21.00 | -$277,893.00 |
0
|
Oct 24 - Oct 25
| |||
Form 4
| +20.86% | 2.09K |
$6.11 | $12,745.46 | 12.09K |
Apr 29 - Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
∞
| 10K |
$7.83 | $78,266.00 | 10K |
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Flexion Therapeutics Inc No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||